Overview
Industry: Pharmaceutical Manufacturing
Headquarters: Monufia, Egypt
Founding Year: 1998
Company Type: Partnership
Company Size: 501-1,000 employees
SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE is a prominent entity in the pharmaceutical manufacturing sector. Established in 1998 and headquartered in the Mubarak 1st Industrial Zone, Monufia, Egypt, the company excels in producing, manufacturing, and exporting generic pharmaceutical products.
Product Portfolio
The company's diverse product line includes:
- Aciloc
- Balsam
- Alvital
- Calma Baby
- Congestal
- Contramal
- Clindam
- Depolvix
These products significantly contribute to the company's revenue and market influence.
Financial Overview
SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE's financial health is buoyed by its extensive product portfolio and strategic market endeavors. Specific financial metrics such as revenue and profit margins were not disclosed but indicate a positive performance trend.
Location & Facilities
Headquarters
Address: Mubarak 1st Industrial Zone, Monufia, Egypt
Facilities
The company operates its main manufacturing and logistical facilities within its headquarters in Mubarak Industrial Zone. This centralization affords strategic benefits in logistics and supply chain management.
Key Personnel
Leadership
- El Sayed El Badawy Mohamed Shehata - Chief Executive Officer (CEO)
El Sayed El Badawy Mohamed Shehata directs the company’s strategic initiatives and operational activities, having successfully expanded both the market reach and product range.
Senior Management
- Hussain Dars - Technical Director
- Walaa Nassar - Network and System Administrator
- Mohamed Aboulfottoh - Country Manager
- Wael Taha - Director of Information Technology
Wael Taha, with over 30 years in IT, ensures that the company’s technological framework supports its strategic objectives.
Department Heads
- Ibrahim Sayed - Graduated from Faculty of Science, South Valley University
- Mohammad Goda - Methodology & Stability Section Head
- Mokhtar Abd El Salam - Customers Department Manager
- Mansour Hassan El-Khateeb - HR Section Head
Competitive Landscape
SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE operates in a competitive market. Its strategy hinges on the production of quality generic pharmaceuticals to distinguish itself from regional and global competitors.
Competitors
Sixth Avenue Medical Pharmacy
- Location: Spokane, Washington, USA
- Services: Free city delivery, hormone & impotence therapy, pain management, veterinary medications, compounding.
- Company Size: 11-50 employees
- Website: [sixthavenuepharmacy.com](http://www.sixthavenuepharmacy.com/)
Fairmont Pharmacy
- Location: Pasadena, California, USA
- Services: Medicinal compounding, home health care, durable medical equipment, medical supply inventory.
- Company Size: 11-50 employees
- Website: [fairmontpharmacy.com](http://www.fairmontpharmacy.com/)
Telesys srl
- Location: Italy
- Services: Software solutions including platform, cloud technology, application and services.
- Website: [telesyssrl.it](http://www.telesyssrl.it)
Golden Springs Pharmacy
- Location: Anniston, Alabama, USA
- Company Size: 11-50 employees
- Website: Not specified
B. McLaughlin Associates, Inc (BMA)
- Location: West Chester, Pennsylvania and Phoenix, Arizona, USA
- Services: Clinical research support, data management, study management. Extensive experience in areas such as biologics, cardiovascular, CNS, dermatology, endocrinology, gastroenterology, and more.
- Company Size: 11-50 employees
- Founded: 1993
- Website: [bmaresearch.com](http://www.bmaresearch.com/)
Strategic Implications
- Service Specializations: Competitors offer diverse services such as compounding (Sixth Avenue Medical Pharmacy, Fairmont Pharmacy) and clinical research support (B. McLaughlin Associates, Inc).
- Geographic Footprint: Competitors primarily operate in the USA and Italy, highlighting a focus on Western markets.
Strategic Insights
- Differentiation: To maintain a competitive edge, SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE should consider expanding service lines or enhancing product offerings.
- Expansion: Exploring market penetration in regions like the USA could present growth opportunities.
- Technology Integration: Leveraging advanced technology solutions, similar to those employed by Telesys srl, could improve operational efficiency and customer satisfaction.
Compiling these critical elements of SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE alongside an analysis of its competitive landscape provides a detailed foundation for strategic planning and market positioning.
